Objective.-This study evaluated the association between migraine and the markers of carotid artery disease. Background.-Migraine increases the risk of cardiovascular events, but its relationship with vascular dysfunction is unclear. Methods.-In this cross-sectional study, middle-aged women with no known cardiovascular diseases underwent clinical, neurological, and laboratory evaluations; pulse wave velocity (PWV) assessment; and carotid artery ultrasonography. We divided the participants based on the presence of migraine and, further, based on the type of migraine. Associations between migraine and carotid thickening (intima-media thickness >0.9 mm), carotid plaques, or arterial stiffening (PWV >10 m/s) were evaluated using a multiple regression analysis.
INTRODUCTION
Cardiovascular disease (CVD) is the leading cause of death worldwide. Migraine is associated with increased risks of coronary artery 1 and cerebrovascular diseases, 2 and CVD-related mortality is high among women who have migraine with aura (MA). 3 The pathophysiological mechanisms of the relationship between migraine and CVD remain unexplained and may include systemic vascular disease.
Most CVDs are directly related to atherosclerotic vascular disease, a slowly progressive inflammatory disease involving fat deposition in the arterial wall. 4 Furthermore, arteriosclerosis is a broader vascular dysfunction which also involves structural remodeling of the arteries, mainly due to vascular aging. 5 Moreover, vascular stiffening in arteriosclerosis is intrinsically related to the atherosclerosis process, 6 possibly representing a continuum. 7 Vascular diseases related to both arteriosclerotic and atherosclerotic processes probably result from a lifelong exposure to vascular risk factors and concurrent damage to the endothelium, resulting in endothelial dysfunction due to oxidative stress and predisposition to CVD. [4] [5] [6] Although the relationship between oxidative stress and migraine is uncertain, 8 pathogenic migraine mechanisms can be generators of oxidative stress. 9 Pulse wave velocity (PWV) evaluation and carotid artery imaging, among other parameters, allow mapping of the arterial disease process and can thus be used for the assessment of the vascular phenotype. 5 Carotid artery imaging via ultrasonography is a noninvasive method that is widely used to assess the subclinical structural markers of vascular damage. [10] [11] [12] Carotid thickening is the first detectable stage of an atherosclerotic disease, 11 but is also found with vascular aging. 10 Carotid intima-media thickness (CIMT) can easily be measured using ultrasonography and correlates well with pathologic findings in the arterial wall. 10, 11, 13 Additionally, carotid imaging further identifies advanced stages of atherosclerosis, such as plaques and stenosis, either in the absence of or concurrent with diffuse carotid thickening. 10, 13 Any sign of carotid artery damage is an independent predictor of overall vascular or specified cerebrovascular events.
14 Increased CIMT is an independent, strong predictor of future vascular events, 11,15,16 while carotid plaques independently predict cardiac events and CVD recurrence in patients who have had an ischemic stroke. 14, 17 Moreover, PWV measurement is the most appropriate method to assess arterial stiffness, 18, 19 and the identification of increased PWV improves risk discrimination of the first cardiovascular event. 6, 18 However, the relationship between migraine and arterial stiffening [20] [21] [22] [23] [24] or carotid artery disease 20, [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] is controversial. Hence, this study aimed to evaluate the association between migraine and the markers of vascular damage, namely carotid thickening, carotid plaques, and arterial stiffening, in middle-aged women.
METHODS
Participants.-This cross-sectional study is an arm of a previous study designed to assess the cardiovascular risk factors in middle-aged women. 36 Among these women, we recruited 304 participants with no known CVD, who were aged 45 to 65 years, and were referred from 2 primary care gynecologic clinics in Recife, Brazil, from May 2011 to June 2012. The exclusion criteria were pregnancy, history of smoking within the preceding 5 years, and use of hormone therapy or intrauterine devices. We expected to include by convenience at least 250 subjects based on previous studies on the association between migraine and vascular disease. 23, 26 All the participants provided written informed consent, and the study protocol was approved by the local ethics committee of the Complexo Hospitalar (Hospital Universitário Oswaldo Cruz and Pronto Socorro Cardiológico de Pernambuco) from Universidade de Pernambuco in Recife, Brazil (approval number CAAE-0135.0.106.000-10).
Evaluations.-We collected participants' demographics and medical data from the baseline database, including age; self-reported race; duration of formal education; monthly family income; prior diagnosis or treatment of hypertension, diabetes, and dyslipidemia; family history of CVD; sedentary lifestyle; waist circumference and body mass index; and mean of 2 blood pressure recordings, previously obtained at a 5-min interval using an automated sphygmomanometer (OMRON-742, Japan). Obesity was defined as a body mass index ≥30 kg/m 2 .
Moreover, we collected laboratory test data, including total cholesterol, high-density lipoproteins cholesterol, and triglycerides levels measured in a venous blood sample collected early in the morning after 12 hours of fasting. We also collected the apnea-hypopnea index from the results of a portable overnight sleep test (Embletta, PDS; Medcare, Reykjavik, Iceland) performed in the sleep laboratory. Obstructive sleep apnea was defined as an apneahypopnea index >5 events per hour. 36 We calculated the general cardiovascular risk profile using the algorithm from the Framingham Heart Study, including age, high-density lipoproteins and total cholesterol levels, systolic blood pressure, smoking habit, and diabetes. The Framingham risk score of 13 points or more corresponds to a high 10-year risk of CVD for women. 37 Anxiety and depression were also assessed using the hospital anxiety and depression scale and a case was symptomatic when there were at least 8 points in each anxiety or depression subscale.
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Headache Diagnosis.-A headache expert neurologist, blinded to the results of the vascular evaluation, interviewed all women, using a semistructured questionnaire, to assess the occurrence and characteristics (duration of episodes, month frequency, and intensity of pain) of headaches and performed a neurologic examination to exclude secondary disorders. Migraine was diagnosed using the third editionbeta of the International Classification of Headache Disorders criteria. 39 The participants were divided into migraine (including probable migraine) and nonmigraine groups, and then the migraine group was further divided into the MA and migraine without aura (MO) groups. Carotid Artery Assessment.-The participants underwent high-resolution B-mode carotid artery ultrasonography (EnVisor ultrasound system with a 12-3 MHz linear transducer; Philips Electronics, Best, Netherlands), performed by a radiologist blinded to the headache diagnosis. Images of a 10-mm segment at the far wall of the distal common carotid arteries were obtained and examined using a semiautomated edge-detection software package (QLAB Intima-Media Thickness; Philips Electronics, Best, Netherlands).
The mean of the best 3 quality measurements of the maximum CIMT from both sides was calculated. Mean CIMT >0.9 mm was classified as increased CIMT or carotid thickening, 40 which indicates diffuse carotid damage. Any focal thickening of the arterial wall above 1.5 mm or any protrusion into the vessel lumen by at least 0.5 mm or 50% of the surrounding wall was classified as carotid plaque, 40 which indicates focal carotid damage. Carotid-Femoral PWV Assessment.-A cardiologist blinded to the study parameters and goals calculated the PWV of the participants as the ratio of the distance (meters) between the probes placed over the right common carotid and femoral artery and the delay in time (seconds) of the pulse wave measured via applanation tonometry (Complior SP; Artech-Medical Co., Paris, France). We classified the mean of 3 consecutive measurements ≥10.0 m/s as increased aortic PWV, which indicates arterial stiffening.
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Statistical Analysis.-We reported frequencies as absolute numbers and percentages. Continuous data were reported as the median and interquartile range. The distribution of the data was non-normal according to the Kolmogorov-Smirnov test.
Chi-square and Mann-Whitney U-tests for independent samples were used to compare migraine subtypes and non-migraine groups. Spearman's coefficient (r s ) was calculated to study the correlation between continuous variables. Missing data were handled by pairwise deletion method in the analysis.
We performed a multiple regression analysis to identify any association between migraine and the markers of vascular damage. Explanatory variables included in the regression models were age (≥55 years old or younger), family income (up to twice the Brazilian minimum wage or higher), and diagnosis of obstructive sleep apnea for diffuse carotid thickening; age, treatment for dyslipidemia or diabetes, and systolic hypertension (≥140 mmHg or lower) for carotid plaques; age, low family income, systolic hypertension, and treatment for diabetes for arterial stiffening.
All explanatory variables were sequentially included individually by a stepwise method if they had P < .10 in the univariate correlation analysis. At each step, we assessed collinearity by comparing the standard errors' variation when further variables were added to the model. Thus, variables were excluded from the analysis if the standard error increased more than 10% indicating the loss of stability and the decision of which variable to remove was based on biological plausibility. 41 The results are presented as odds ratios and 95% confidence intervals (95% CI). The internal validation of the final models was assessed by bootstrap techniques and we presented bias-corrected 95% CI for each regression coefficient (β) based on the analyses of 1000 computer-generated bootstrap samples.
Statistical power was not calculated prior to the study. Statistical significance was considered to be a two-sided P value <.05. Data were analyzed with the SPSS Statistics Software version 21.0 (IBM Corporation, Armonk, NY, USA).
RESULTS
A total of 277/304 (91%) women were included in the final sample after applying the exclusion criteria (Fig. 1) . The characteristics of the participants who did not undergo either of the vascular studies were not different from those of the participants who underwent the evaluations. Table 1 shows the number of participants according to migraine diagnosis and the characteristics of each study group. Migraine was diagnosed in 112/277 (40%) women, and 46/277 (17%) women had MA. Compared to non-migraineurs, women with MA were younger and had a higher frequency A multiple regression analysis based on the comparison of the participants with migraine subtypes and non-migraineurs for the markers of arterial disease is shown in Table 2 . We found that MA increased the risk of diffuse carotid thickening, while MO was associated with a low risk of carotid plaques and arterial stiffening. An internal validation with the bootstrap technique showed: β = 1.96 (95% CI −17.75, 17.32) for the MA and carotid thickness model; β = −1.28 (95% CI −3.12, −0.45) for the MO and carotid plaques model; and β = −0.77 (95% CI −1.54, −0.17) for the MO and arterial stiffening model.
Applanation tonometry
Moreover, we did not find any correlation between migraine characteristics and the PWV measurement (episode duration: r s = −0.12, P = .114; monthly frequency: r s = 0.04, P = .657; pain intensity: r s = 0.005, P = .946) or the CIMT measurement (episode duration: r s = −0.07, P = .388; monthly frequency: r s = 0.008, P = .916; pain intensity: r s = 0.05, P = .551). 
DISCUSSION
We found that MA was associated with an increased risk of diffuse carotid thickening in middle-aged women. In contrast, the risks of carotid plaques and arterial stiffening were lower in the MO group than in the non-migraineurs.
To our knowledge, this is the first study to evaluate the prevalence of the markers of vascular damage in migraineurs. We chose this approach because abnormally high values of the studied markers are more likely to be associated with increased individual risk for future CVD than the average values in a specified population. 5 Thus, the prevalence of arterial damage and not average CIMT or PWV values was assumed to be more reasonable to assess vascular health in migraineurs. We found no difference in the median CIMT in terms of migraine diagnosis, similar to the results of most previous studies on the relationship between CIMT and migraine. 20, 23, 25, 29, 30, 32, 34 In the present study, the increased risk of carotid thickening in association with MA is unique. Intima-media thickening is the result of the accumulation of vascular-like smooth muscle neointimal cells, and it is possibly the earliest structural hallmark associated with oxidative stress in the arteriosclerosis of medium-sized vessels. 10, 42 Given the direct correlation between CIMT and CVD, 12 carotid thickening should be considered a vascular disorder in itself, and not only a surrogate marker. Some evidence suggests that increased CIMT and carotid plaques are biologically different. The latter are strongly influenced by environmental factors with distinctive natural history, 13, 43 whereas the former can reflect non-atherosclerotic remodeling of the arterial wall and may be associated with an early vascular aging process. 13 Although it is possible to detect carotid thickening without atherosclerotic plaques as a vascular phenotype in MA, we noted that women with MA tended to have more carotid plaques than non-migraineurs. Moreover, the prevalence of plaques associated with MA was significantly higher than that associated with MO. Hence, it is reasonable to assume that diffuse carotid thickening in our patients might subsequently result in more carotid plaques in relation to MA.
Oxidative stress and endothelial dysfunction, possibly triggered by exposure to vascular risk factors, appear to be the cause of vascular damage causing CVDs. 4, 6 However, in migraineurs, some markers of endothelial dysfunction 3, 44 and CVDs 11,12 may be observed regardless of conventional risk factors. In this study, we also found that carotid thickening was not associated with these factors, indicating that migraine may be a risk factor in itself. Endothelial dysfunction is characterized by a reduction in nitric oxide-dependent vasodilation and a state of endothelial activation, which includes a proinflammatory, proliferative, and procoagulatory milieu. 45, 46 Although many studies indicate that endothelial function is not clearly impaired in relation to MA, 45 there is promising evidence showing an increase in the markers of endothelial activation in migraineurs. 46 Endothelial activation with prothrombotic changes might be uncoupled from or occur prior to the development of atherosclerosis in migraineurs and cause vascular events.
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Oxidative stress is usually associated with endothelial dysfunction and carotid thickening. 42 During migraine attacks, reactive oxygen species are generated and calcitonin gene-related peptide is released and directly activates the vascular smooth muscle cells, enhances nitric oxide production by the endothelial cells, and activates the production of unstable reactive nitric oxide species. 8, 9, 46 Hence, frequent or long-lasting migraine attacks can increase oxidative stress and promote the vascular phenomena linked to migraine, especially in predisposed individuals with decreased antioxidant defense. 9 Although these factors were not examined in our study, we suggest that the impairment of reactive oxygen species regulatory systems that causes endothelial activation could be a possible link between MA and carotid thickening. The prevalence of plaques when measuring the atherosclerotic burden appears better than with the CIMT measurement. 12 The relationship between carotid plaques and migraine is unclear since the presence of stenosis or plaques is often assumed as an exclusion criterion. 29, 31 A few studies have mentioned these markers of advanced vascular damage in migraineurs. 26, 27, 31, 35 However, we found no difference in the prevalence of carotid plaques based on migraine diagnosis, which is similar to the results of the only study that clearly reported such findings. 26 In addition, we found that MO is associated with a lower risk of carotid plaques. The relationship between CVD and MO is unclear because MO appears not associated with myocardial infarction 1 or ischemic stroke. 2 Our results suggest that if MO is associated with CVD, it may not be caused by atherosclerosis. By comparing only the arterial stiffness measurements, we found no differences in the median PWV values according to the migraine diagnosis, as also reported in other previous studies. 20, 23 However, MO was also associated with a lower risk of arterial stiffening than that in non-migraineurs in our study. Arterial stiffness measurement indicates the elastic wall properties of the large arteries, and the stiffening process is a marker of vascular aging, possibly related to oxidative stress and endothelial dysfunction. 21, 22 Epidemiological evidence suggests a higher susceptibility of migraineurs to cerebral than cardiac events. 1 Moreover, endothelial dysfunction may prevail in cerebral arteries. 45 Although our findings suggest that migraine is possibly not associated with arteriosclerosis, arterial stiffness is a measure of PWV in the aorta and may not directly reflect carotid damage.
The present study has some limitations. We intended to recruit women consecutively to improve sampling and to minimize selection bias. Including only middle-aged women limits generalizability, mainly because some evidence demonstrated increased progression rate of CIMT during menopause transition. 47 Moreover, information bias is often a problem in cross-sectional studies. We assumed that recall bias would not be a problem since we used only the current headache status for migraine diagnosis and objective methods to measure the markers of vascular dysfunction. Although the study design is not appropriate for testing a hypothesis, we attempted to adjust for confounders, using an extensive database, possibly including not all, but most of the factors that possibly influence the relationship between migraine and vascular dysfunction. One study showed that prophylactic migraine drugs improve PWV. 24 Hence, we cannot rule out the interference of specified treatments in PWV measurements or other parameters, as we did not include these data in the analysis. We did not include women with prior CVD, and we therefore cannot rule out the possibility that the markers of vascular damage are underestimated in migraineurs. Moreover, some risk estimates are highly imprecise as demonstrated by wide confidence intervals resulting from low event rates. However, we have tried to control the stability of the regression models strictly, and we found statistically significant associations. The results should be interpreted carefully because the bootstrap analysis revealed some fragilities. Future studies should include larger samples, extend the age range, include male participants, and focus on factors other than only average CIMT or PWV. Hence, they should use reasonable cut-offs and study the prevalence of diffuse carotid thickening, plaques or stenosis, and arterial stiffening.
CONCLUSION
We found in this study that MA increased the risk of diffuse carotid thickening and MO was associated with a low risk of carotid plaques and arterial stiffening. Thus, evaluating CIMT appears to be a useful marker of vascular damage in migraineurs, and carotid thickening is possibly related to a migraine-specific mechanism of vascular dysfunction. Given that carotid ultrasonography is simple and easily available, it should be considered for the assessment of vascular health in migraineurs in neurological practice. 
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